- Home
- HMY vs TECH Comparison
HMY vs TECH Comparison
Compare HMY & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMY
- TECH
- Stock Information
- Founded
- HMY 1950
- TECH 1976
- Country
- HMY South Africa
- TECH United States
- Employees
- HMY N/A
- TECH N/A
- Industry
- HMY Precious Metals
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HMY Basic Materials
- TECH Health Care
- Exchange
- HMY Nasdaq
- TECH Nasdaq
- Market Cap
- HMY 7.5B
- TECH 7.9B
- IPO Year
- HMY N/A
- TECH 1989
- Fundamental
- Price
- HMY $14.14
- TECH $47.86
- Analyst Decision
- HMY Sell
- TECH Buy
- Analyst Count
- HMY 2
- TECH 10
- Target Price
- HMY $6.60
- TECH $73.44
- AVG Volume (30 Days)
- HMY 5.8M
- TECH 2.3M
- Earning Date
- HMY 01-01-0001
- TECH 05-07-2025
- Dividend Yield
- HMY 1.05%
- TECH 0.67%
- EPS Growth
- HMY 16.30
- TECH N/A
- EPS
- HMY 0.88
- TECH 0.83
- Revenue
- HMY $3,553,951,394.00
- TECH $1,208,770,000.00
- Revenue This Year
- HMY $23.09
- TECH $8.19
- Revenue Next Year
- HMY $12.83
- TECH $8.61
- P/E Ratio
- HMY $15.68
- TECH $57.61
- Revenue Growth
- HMY 16.84
- TECH 4.72
- 52 Week Low
- HMY $7.97
- TECH $46.44
- 52 Week High
- HMY $18.77
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- HMY 43.07
- TECH 41.02
- Support Level
- HMY $14.69
- TECH $46.77
- Resistance Level
- HMY $16.54
- TECH $54.40
- Average True Range (ATR)
- HMY 0.48
- TECH 2.12
- MACD
- HMY -0.33
- TECH 0.45
- Stochastic Oscillator
- HMY 17.70
- TECH 14.29
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.